Crescent Biopharma
CBIO
13.49
-0.08
-0.59%
Crescent Biopharma
US · CBIO
#3749 by market cap
13.49
-0.08
-0.59%
Live - 5344 symbols - heartbeat 17s ago
· 2026-10-08 02:25
After-hours
13.49
0.00%
Overnight
13.16
-2.45%
- Market cap
- 501.07M
- P/E (TTM)i
- -96.36
- P/Bi
- 3.15
- EPSi
- -12.81
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on CBIO?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 4 analysts
Buy
Avg price target
29.75 +120.5%
Price target rangecurrent 13.49
Low27.00
Avg29.75
High36.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-06 | Stifel | -- | BUY | 28.00 |
| 2026-10-06 | H.C. Wainwright | -- | BUY | 36.00 |
| 2026-10-05 | LifeSci Capital | -- | BUY | 28.00 |
| 2026-09-14 | Wedbush | -- | BUY | 27.00 |
| 2026-07-31 | Stifel | -- | BUY | 28.00 |
| 2026-07-31 | H.C. Wainwright | -- | HOLD | -- |
| 2026-07-30 | LifeSci Capital | -- | BUY | 28.00 |
| 2026-07-16 | H.C. Wainwright | -- | HOLD | -- |
| 2026-06-23 | Piper Sandler | -- | BUY | 35.00 |
| 2026-06-23 | Stifel | -- | BUY | 30.00 |
| 2026-06-01 | Stifel | -- | BUY | 30.00 |
| 2026-06-01 | H.C. Wainwright | -- | HOLD | -- |
| 2026-05-26 | Piper Sandler | -- | BUY | 35.00 |
| 2026-05-04 | H.C. Wainwright | -- | BUY | 22.00 |
| 2026-04-30 | LifeSci Capital | -- | BUY | 28.00 |
| 2026-04-30 | Piper Sandler | -- | BUY | 35.00 |
| 2026-04-30 | Wedbush | -- | BUY | 27.00 |
| 2026-04-30 | Stifel | -- | BUY | 30.00 |
| 2026-04-29 | TD Cowen | -- | BUY | -- |
| 2026-04-29 | Guggenheim | -- | BUY | 35.00 |
| 2026-04-22 | Piper Sandler | -- | BUY | 35.00 |
| 2026-04-10 | Piper Sandler | -- | BUY | 35.00 |
| 2026-03-02 | H.C. Wainwright | -- | BUY | 22.00 |
| 2026-02-26 | TD Cowen | -- | BUY | -- |
| 2026-02-26 | LifeSci Capital | -- | BUY | 22.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: H.C. Wainwright moved from Hold to Buy on 2026-10-06.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-06 | H.C. Wainwright | HOLD → BUY | 36.00 |
| 2026-06-01 | H.C. Wainwright | BUY → HOLD | -- |
Quote time 2026-10-08 02:25:01 · For reference only, not investment advice and not tailored to your situation.